Unknown

Dataset Information

0

Macrophage-mediated delivery of light activated nitric oxide prodrugs with spatial, temporal and concentration control.


ABSTRACT: Nitric oxide (NO) holds great promise as a treatment for cancer hypoxia, if its concentration and localization can be precisely controlled. Here, we report a "Trojan Horse" strategy to provide the necessary spatial, temporal, and dosage control of such drug-delivery therapies at targeted tissues. Described is a unique package consisting of (1) a manganese-nitrosyl complex, which is a photoactivated NO-releasing moiety (photoNORM), plus Nd3+-doped upconverting nanoparticles (Nd-UCNPs) incorporated into (2) biodegradable polymer microparticles that are taken up by (3) bone-marrow derived murine macrophages. Both the photoNORM [Mn(NO)dpaqNO2 ]BPh4(dpaqNO2 = 2-[N,N-bis(pyridin-2-yl-methyl)]-amino-N'-5-nitro-quinolin-8-yl-acetamido) and the Nd-UCNPs are activated by tissue-penetrating near-infrared (NIR) light at ?800 nm. Thus, simultaneous therapeutic NO delivery and photoluminescence (PL) imaging can be achieved with a NIR diode laser source. The loaded microparticles are non-toxic to their macrophage hosts in the absence of light. The microparticle-carrying macrophages deeply penetrate into NIH-3T3/4T1 tumor spheroid models, and when the infiltrated spheroids are irradiated with NIR light, NO is released in quantifiable amounts while emission from the Nd-UCNPs provides images of microparticle location. Furthermore, varying the intensity of the NIR excitation allows photochemical control over NO release. Low doses reduce levels of hypoxia inducible factor 1 alpha (HIF-1?) in the tumor cells, while high doses are cytotoxic. The use of macrophages to carry microparticles with a NIR photo-activated theranostic payload into a tumor overcomes challenges often faced with therapeutic administration of NO and offers the potential of multiple treatment strategies with a single system.

SUBMITTER: Evans MA 

PROVIDER: S-EPMC5939611 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Macrophage-mediated delivery of light activated nitric oxide prodrugs with spatial, temporal and concentration control.

Evans Michael A MA   Huang Po-Ju PJ   Iwamoto Yuji Y   Ibsen Kelly N KN   Chan Emory M EM   Hitomi Yutaka Y   Ford Peter C PC   Mitragotri Samir S  

Chemical science 20180316 15


Nitric oxide (NO) holds great promise as a treatment for cancer hypoxia, if its concentration and localization can be precisely controlled. Here, we report a "Trojan Horse" strategy to provide the necessary spatial, temporal, and dosage control of such drug-delivery therapies at targeted tissues. Described is a unique package consisting of (1) a manganese-nitrosyl complex, which is a photoactivated NO-releasing moiety (photoNORM), plus Nd<sup>3+</sup>-doped upconverting nanoparticles (Nd-UCNPs)  ...[more]

Similar Datasets

| S-EPMC2808138 | biostudies-literature
| S-EPMC2631658 | biostudies-literature
| S-EPMC7770715 | biostudies-literature
| S-EPMC6939382 | biostudies-literature
| S-EPMC7410342 | biostudies-literature
2014-12-22 | E-MEXP-3959 | biostudies-arrayexpress
| S-EPMC7221075 | biostudies-literature
| S-EPMC2928551 | biostudies-literature
| S-EPMC3896098 | biostudies-literature
| S-EPMC7363046 | biostudies-literature